Furthermore, crocetin (CRO) has been reported to downregulate total cholesterol (TC) and cholesterol esters (CE), effectively limiting lipid droplet formation and activating PPARγ/LXR-α to facilitate reverse cholesterol transport, thereby ameliorating atherosclerosis (99). The gene discussed is PPARG; the disease is atherosclerosis.